| Application no. and date | 13177190.9 (espacenet) (Federated) (European Patent Register), 20091216 | | Patent/reg. no. and date | DK/EP 2676953, 20170322 | | Publication date | 20131225 | | Priority no. and date | US 203053 P, 20081218 | | EP pub. no. and date |
EP 2676953 20131225 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/155338 | | Inventor | Ciszewski, Lech, Novartis
One Health Plaza
East Hannover, NJ New Jersey 07936, US,
De La Cruz, Marilyn, Novartis
One Health Plaza
East Hannover, NJ New Jersey 07936, US,
Karpinski, Piotr H., Novartis
One Health Plaza
East Hannover, NJ New Jersey 07936, US,
Mutz, Michael, Novartis Pharma AG
Postfach
4002 Basel, CH,
Riegert, Christian, Novartis Pharma AG
Postfach
4002 Basel, CH,
Vogel, Caspar, Novartis Pharma AG
Postfach
4002 Basel, CH,
Sschneeberger, Ricardo, Novartis Pharma AG
Postfach
4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/397 (2006.01) , A61P 35/00 (2006.01) , A61P 37/00 (2006.01) , C07D 205/04 (2006.01) | | Title | Hemifumaratsalt af 1-[4-[1-(4-cyclohexyl-3-trifluormethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl]-acetidin-3-carboxylsyre til anvendelse ved behandling af lymfocytmedierede sygdomme | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
